Stockreport

China Biopsy Market Report 2024-2032: Chinese Government Releases 8 Year Plan for Cancer Prevention and Treatment, to Achieve 46.6% Five Year Survival Rate among Cancer Patients by 2030 [Y...

Bio-Rad Laboratories, Inc. Class A  (BIO) 
Last bio-rad laboratories, inc. class a earnings: 2/13 04:15 pm Check Earnings Report
PDF China's biopsy device Market share is expected to be almost US$ 1,059.41 Million by 2032 compared to US$ 574.31 Million in 2023. The industry is forecast to increase at [Read more]